Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bayer AG | 47 | 5 | 2 | 0 | €49.94 | €72.00 | 44.187% |
| Fresenius SE & Co. KGaA | 30 | 3 | 4 | 0 | €45.18 | €57.50 | 27.283% |
| Evotec AG | 25 | 1 | 1 | 0 | €35.75 | €40.00 | 11.888% |
| Pfizer Inc. | 26 | 3 | 1 | 0 | €38.17 | €37.48 | -1.820% |
| Gilead Sciences Inc | 21 | 5 | 1 | 0 | €58.49 | €80.00 | 36.776% |
| Fresenius Medical Care AG & Co KGaA ST | 18 | 2 | 1 | 0 | €67.30 | €80.00 | 18.871% |
| Johnson & Johnson | 16 | 0 | 2 | 0 | €146.46 | €150.00 | 2.417% |
| AbbVie Inc. | 12 | 0 | 1 | 0 | €97.21 | €105.00 | 8.014% |
| Novo Nordisk A/S | 12 | 1 | 2 | 1 | €82.80 | €85.00 | 2.657% |
| Canopy Growth Corp | 12 | 1 | 0 | 0 | €15.45 | €26.50 | 71.565% |
| Palatin Technologies | 11 | 1 | 0 | 0 | €0.42 | €1.00 | 138.379% |
| Vertex Pharmaceuticals Inc. | 10 | 0 | 0 | 0 | €168.56 | €210.60 | 24.941% |
| Bristol-Myers Squibb | 9 | 0 | 0 | 0 | €57.86 | €62.00 | 7.155% |
| Organigram Holdings Inc. | 9 | 0 | 0 | 0 | €2.10 | €7.00 | 233.492% |
| Medtronic plc | 9 | 0 | 3 | 0 | €108.45 | €120.00 | 10.650% |
| Aphria Inc. | 10 | 1 | 0 | 0 | €12.71 | €15.80 | 24.360% |
| Abbott Laboratories | 8 | 0 | 1 | 0 | €102.70 | €110.00 | 7.108% |
| Sanofi S.A. | 8 | 0 | 1 | 0 | €84.58 | €101.00 | 19.414% |
| Illumina Inc. | 8 | 0 | 1 | 0 | €426.20 | €452.24 | 6.109% |
| Eli Lilly Corp. | 8 | 0 | 0 | 0 | €221.70 | €216.50 | -2.346% |
| Novartis AG ADR | 8 | 0 | 0 | 0 | €77.40 | €92.00 | 18.863% |
| AstraZeneca plc | 9 | 1 | 0 | 0 | €96.73 | €110.00 | 13.719% |
| Amgen Inc. | 9 | 1 | 0 | 0 | €192.86 | €227.50 | 17.961% |
| Alexion Pharmaceutical Inc. | 8 | 0 | 0 | 0 | €154.78 | €157.50 | 1.757% |
| Veeva Systems A | 8 | 0 | 1 | 0 | €288.10 | €300.00 | 4.131% |
